BIOMAT Database Logo BIOMAT Database Logo

Novel selective inhibitors of aminopeptidases that generate antigenic peptides. 2013

Athanasios Papakyriakou, and Efthalia Zervoudi, and Emmanuel A Theodorakis, and Loredana Saveanu, and Efstratios Stratikos, and Dionisios Vourloumis
Department of Chemistry & Biochemistry, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0358, USA.

Endoplasmic reticulum aminopeptidases, ERAP1 and ERAP2, as well as Insulin regulated aminopeptidase (IRAP) play key roles in antigen processing, and have recently emerged as biologically important targets for manipulation of antigen presentation. Taking advantage of the available structural and substrate-selectivity data for these enzymes, we have rationally designed a new series of inhibitors that display low micromolar activity. The selectivity profile for these three highly homologous aminopeptidases provides a promising avenue for modulating intracellular antigen processing.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D010122 Cystinyl Aminopeptidase A zinc-containing sialoglycoprotein that is used to study aminopeptidase activity in the pathogenesis of hypertension. EC 3.4.11.3. Cystine Arylamidase,Cystyl Aminopeptidase,Oxytocinase,Cystidyl Aminopeptidase,Cystinaminopeptidase,Cystine Aminopeptidase,Vasopressinase
D004721 Endoplasmic Reticulum A system of cisternae in the CYTOPLASM of many cells. In places the endoplasmic reticulum is continuous with the plasma membrane (CELL MEMBRANE) or outer membrane of the nuclear envelope. If the outer surfaces of the endoplasmic reticulum membranes are coated with ribosomes, the endoplasmic reticulum is said to be rough-surfaced (ENDOPLASMIC RETICULUM, ROUGH); otherwise it is said to be smooth-surfaced (ENDOPLASMIC RETICULUM, SMOOTH). (King & Stansfield, A Dictionary of Genetics, 4th ed) Ergastoplasm,Reticulum, Endoplasmic
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000626 Aminopeptidases A subclass of EXOPEPTIDASES that act on the free N terminus end of a polypeptide liberating a single amino acid residue. EC 3.4.11. Aminopeptidase
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs

Related Publications

Athanasios Papakyriakou, and Efthalia Zervoudi, and Emmanuel A Theodorakis, and Loredana Saveanu, and Efstratios Stratikos, and Dionisios Vourloumis
Optimization and Structure-Activity Relationships of Phosphinic Pseudotripeptide Inhibitors of Aminopeptidases That Generate Antigenic Peptides.
October 2016, Journal of medicinal chemistry,
Athanasios Papakyriakou, and Efthalia Zervoudi, and Emmanuel A Theodorakis, and Loredana Saveanu, and Efstratios Stratikos, and Dionisios Vourloumis
Processing of antigenic peptides by aminopeptidases.
June 2004, Biological & pharmaceutical bulletin,
Athanasios Papakyriakou, and Efthalia Zervoudi, and Emmanuel A Theodorakis, and Loredana Saveanu, and Efstratios Stratikos, and Dionisios Vourloumis
Regulating adaptive immune responses using small molecule modulators of aminopeptidases that process antigenic peptides.
December 2014, Current opinion in chemical biology,
Athanasios Papakyriakou, and Efthalia Zervoudi, and Emmanuel A Theodorakis, and Loredana Saveanu, and Efstratios Stratikos, and Dionisios Vourloumis
ER aminopeptidases generate a unique pool of peptides for MHC class I molecules.
July 2001, Nature immunology,
Athanasios Papakyriakou, and Efthalia Zervoudi, and Emmanuel A Theodorakis, and Loredana Saveanu, and Efstratios Stratikos, and Dionisios Vourloumis
Novel epoxysuccinyl peptides. Selective inhibitors of cathepsin B, in vitro.
March 1991, FEBS letters,
Athanasios Papakyriakou, and Efthalia Zervoudi, and Emmanuel A Theodorakis, and Loredana Saveanu, and Efstratios Stratikos, and Dionisios Vourloumis
Liporetro-D-peptides - a novel class of highly selective thrombin inhibitors.
April 2012, Thrombosis research,
Athanasios Papakyriakou, and Efthalia Zervoudi, and Emmanuel A Theodorakis, and Loredana Saveanu, and Efstratios Stratikos, and Dionisios Vourloumis
Elucidation of novel TRAP1-Selective inhibitors that regulate mitochondrial processes.
October 2023, European journal of medicinal chemistry,
Athanasios Papakyriakou, and Efthalia Zervoudi, and Emmanuel A Theodorakis, and Loredana Saveanu, and Efstratios Stratikos, and Dionisios Vourloumis
[Aminopeptidases and their inhibitors].
January 1987, Vestnik Akademii meditsinskikh nauk SSSR,
Athanasios Papakyriakou, and Efthalia Zervoudi, and Emmanuel A Theodorakis, and Loredana Saveanu, and Efstratios Stratikos, and Dionisios Vourloumis
Assessment of novel inhibitors of Helicoverpa aminopeptidases as anti-insect agents.
November 2006, Pest management science,
Athanasios Papakyriakou, and Efthalia Zervoudi, and Emmanuel A Theodorakis, and Loredana Saveanu, and Efstratios Stratikos, and Dionisios Vourloumis
Beta-aminoketones as prodrugs for selective irreversible inhibitors of type-1 methionine aminopeptidases.
November 2014, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!